Below is a list of ready-to-go slide decks that Chapter Leaders can use for their Spring or Fall Learning Series. Once a chapter has presented a slide deck, they may not present it again.

2024

Nurse Leaders: Successful Strategies and Tip to Help Along the Way (0.5 CE – 1.0 CE contact hours)

Learning Objectives

  • Describe varying leadership styles applicatable to nursing
  • Discuss application of leadership strategies in nursing
  • Explore the benefits and responsibilities of being a mentor and a mentee

Cardiac Amyloidosis: Increasing Awareness and Understanding (1.0 CE contact hours)

Learning Objectives

  • Review the prevalence and prognosis of risk for cardiac amyloidosis in heart failure patients emphasizing early diagnosis for improved outcomes
  • Discuss the distribution of and inequities in diagnosis and care for cardiac amyloidosis across patient populations including race, ethnicity and gender
  • Examine the evolving signs and symptoms of cardiac amyloidosis subtypes (hereditary and wild type) as seen in diagnostic imaging including evidence-based treatments for each
  • Explore the role of cardiovascular nurse in cardiac amyloidosis treatment and management highlighting promotion of shared-decision making to empower patients to play an active role in their care

Nurse Health and Well-Being (1.0 CE contact hours)

Learning Objectives

  • Identify the physical health concerns found to be prominent in the nursing population.
  • Review the impact of burnout, current workforce issues and stress on the mental health of nurses.
  • Discuss occupational health safety including variations and methods to leverage employer wellness programs and workplace environment issues to promote healthy lifestyles and health attainment by nurse employees.
  • Explore best practices and innovation in self-care and health promotion of the nursing workforce.

2023

Maternal Mortality & Cardiovascular Disease (1.0 CE contact hours)

Learning Objectives

  • Describe cardiovascular and cardiometabolic complications of pregnancy including long term risks across the lifespan.
  • Discuss the impact of social determinants of heath and implicit bias on cardiovascular related maternal mortality.
  • Review current women’s health guidelines, policies and recommendations.
  • Discuss best practices to prevent maternal mortality including improved hypertension monitoring, increased access to perinatal appointments, and more.

A Heart Healthy Lifestyle Counseling: A Focus on the Female Patient (1.0 CE contact hours)

Learning Objectives

  • Identify two pregnancy complications associated with future CVD risk.
  • Describe the integration of brief dietary counseling into a clinical visit.
  • Apply evidence-based interventions to promote physical activity and healthy eating including the PCNA Heart Healthy Toolbox.

Hypertension: Current Guideline Recommendations (1.0 CE contact hours)

Learning Objectives

  • Review current hypertension guidelines.
  • Describe the association between high blood pressure and cardiovascular disease risk.
  • Explain the impact of implicit bias, oppression and discrimination on cardiovascular health.
  • Discuss treatment strategies for hypertension according to patient’s risk level, co-morbidities, race/ethnicity age.

National Guidelines for the Primary Prevention of CVD: Integrating Hypertension, Cholesterol, Diabetes, and Lifestyle Guidelines into Practice (2.0 CE contact hours)

Learning Objectives

  • Cite and locate national guidelines related to CVD Risk Reduction.
  • Understand the class or strength of treatment recommendations in guidelines.
  • Explain how CV risk assessment tools and patient-centered approaches can help to individualize comprehensive management of CV risk.
  • Apply current CVD prevention and risk reduction guidelines to patient care planning for lifestyle, physical activity, obesity, and tobacco use using a case study approach
  • Describe application of current guideline recommendations for diabetes, cholesterol, hypertension, aspirin use, and more.

Learning Objectives

  • Discuss the risk factors associated with undiagnosed and asymptomatic atrial fibrillation.
  • Incorporate effective strategies for early detection of AFib into clinical practice
  • Select tools that can help in communicating risk factors, prevention strategies, and treatment approaches with patients.
  • Identify key aspects of current recommendations on atrial fibrillation, anticoagulation, stroke risk, and prevention approaches.

2022

Beyond Glycemic Control with SGLT2s and GLP1s RAs: New Evidence of Improved Cardiac, Renal, and Obesity Outcomes for Patients With and Without Diabetes (1.0 CE contact hours, 1.0 Pharmacology)

Learning Objectives

  • Explain the role, function, and side effects of SGLT2 inhibitors and GLP1 receptor agonists.
  • Review the current evidence of the cardio-protective effects of SGLT2is and GLP1 RAs including positive outcomes in heart failure treatment and arrythmia reduction.
  • Discuss the weight loss benefit evidence of GLP1 RAs and SGLT2is in the picture of diabetic and nondiabetic patients.
  • Summarize the renal benefits evidence for patients with T2D prescribed SGLT2is or GLP1 RAs.
  • Explore interventions and tools to increase access and adherence to medication using a case study approach.

ASCVD Risk Estimation and Communication (1.0 CE contact hours)

Learning Objectives

  • Describe modifiable and non-modifiable risk factors and enhancers that are known to increase the risk of atherosclerotic cardiovascular disease (ASCVD).
  • Explain currently available ASCVD risk estimation tools.
  • Apply tools that can predict risk for ASCVD across patient populations using a case study approach.
  • Summarize Coronary Artery Calcium Scoring considerations.

The Basics of 12 Lead ECG Interpretation (1.0 CE contact hours)

Learning Objectives

  • Explain which wall of the heart is being affected by abnormalities seen in 12-lead ECGs.
  • Identify which coronary artery is being affected based on 12-Lead ECG findings.
  • Discuss patient care considerations of specific ECG findings including electrolyte imbalances, Takotsubo Cardiomyopathy, QT prolongation, ventricular hypertrophy, atrial enlargement and bundle branch blocks.
  • Apply knowledge of 12-lead interpretation techniques.

2020

Recommending Exercise in those with Obesity and Cardiovascular Risk Factors (1.0 CE contact hours)

Learning Objectives

  • Describe the risk factors for cardiovascular disease and their association with overweight and obesity.
  • Explain the steps in performing a Cardiovascular (CV) risk assessment for exercise clearance.
  • Discuss counseling strategies for prescribing safe and effective exercise.

2019

Peripheral Arterial Disease: Risk Factors, Screening & Treatment (1.0 CE)

Learning Objectives

  • Outline the risk factors associated with PAD.
  • Describe the clinical presentation of patients with PAD.
  • List the steps to perform an Ankle Brachial Index (ABI) to screen for PAD.
  • Discuss common treatments for PAD including a supervised exercise training (SET) program for patients with claudication.

2018

Screening for Non-Valvular Atrial Fibrillation: Identifying the Undiagnosed Patient (1.0 CE)

Learning Objectives

  • Review prevalence and common risk factors associated with non-valvular atrial fibrillation (NVAF).
  • Describe typical signs and symptoms of NVAF and how to assess for them during a clinical encounter.
  • Discuss the importance of pulse taking and follow up ECG to screen high risk patients for NVAF.
  • Using case examples, illustrate how to initiate NVAF treatment, provide follow-up and collaboration across the continuum of care to ensure optimal patient outcomes.

Women’s Cardiovascular Care Across the Life Course – Promoting Prevention Among Women Who Experience Adverse Pregnancy Outcomes (1.0 CE)

Learning Objectives

  • Identify key adverse pregnancy outcomes (APOs) that are associated with future cardiovascular or cardiometabolic risk.
  • Identify persons who are at increased risk for developing these pregnancy-related complications.
  • Describe the cardiovascular or cardiometabolic risk associated with these pregnancy-related complications.
  • Describe clinical guidelines and recommendations for postpartum follow up and risk reduction.
  • Apply evidence-based interventions to promote healthy eating, physical activity, and breastfeeding during the postpartum and childbearing years.